載入...

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

BACKGROUND: The aim of this study was to determine the clinical benefit of transhepatic arterial chemoembolization (TACE) with or without recombinant human adenovirus type 5 (H101) administration for the treatment of patients with hepatocellular carcinoma (HCC). METHODS: Tumor response, progression-...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Cancer
Main Authors: Lin, Xiao-jun, Li, Qi-jiong, Lao, Xiang-ming, Yang, Han, Li, Sheng-ping
格式: Artigo
語言:Inglês
出版: BioMed Central 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4608280/
https://ncbi.nlm.nih.gov/pubmed/26470869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1715-x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!